This most up-to-date twist from the Lykos Therapeutics saga threatens An important overhaul of the corporation’s system and route, with Musk ally and billionaire investor Antonio Gracias showing up to want to choose the corporation back again toward its nonprofit drug enhancement roots and a more Doblinite philosophy.The claimed utilizes of copyr